AstraZeneca to collaborate with Biognosys on large proteome quantification

Today we announce a new collaboration project with AstraZeneca where it will utilize the recently launched Proteome-SEQ™ service from Biognosys.

Proteome-SEQ™ is a comprehensive standardized discovery service for precise quantification of 1000s of proteins in parallel across multiple samples. The service is based on the next-generation proteomics HRM-MS™ technology and addresses research questions where identification of specific protein expression differences against the backdrop of the whole proteome is important. Examples for applications are drug target discovery and biomarker development.


Let us help you do great proteomics!

Please click here to contact us.